Abstract
EGFL7 is a recently identified chemoattractant for endothelial cells that is a prerequisite for vascular tubulogenesis. We examined the effect of hypoxic injury on endothelial cell expression of EGFL7 to determine whether it may be implicated in allograft vasculopathy. Additionally, we investigated the effect of EGFL7 on endothelial cell intercellular adhesion molecule-1 (ICAM-1) expression.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
